CUHK and HKSTP open a new ATP GMP Centre to fast-track the cell and gene therapy (CGT) manufacturing industry in Hong Kong and the GBA
State-of-the-art facility accelerates clinical trials to commercialisation with international PIC/S GMP-compliant manufacturing processes :
- The new ATP GMP Centre will forge a world-class CGT manufacturing industry in Hong Kong and the Greater Bay Area.
- CUHK collaboration boosts HKSTP’s mission to accelerate translation of scientific discoveries into life-saving biomedical innovations.
- The centre features a highly skilled workforce, cluster development and excellent logistics infrastructure, speeding up CGT development.